U.S. STOCKS ON THE MOVE-Carvana, Vistagen, Shoe Carnival
Alzamend Neuro rises on completion of Alzheimer's drug study
Brief: Alzamend Neuro Announces Completion Of Clinical Portion Of Phase Iia Multiple Ascending Dose Clinical Trial For Al001 Treatment Of Dementia Related To Alzheimer’S
Brief: Alzamend Neuro Reports Third Fiscal Quarter Financial Results And Provides A Business Update
U.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Alzamend Neuro Inc Received Notice Of Delisting From Nasdaq
Brief: Alzamend Neuro Partners With Biorasi To Conduct Phase I/IIa Clinical Trial
Brief: Alzamend Neuro Partners With The Miller School Of Medicine
U.S. RESEARCH ROUNDUP- Cognizant Technology Solutions, Fedex, Tesla
U.S. STOCKS ON THE MOVE-Insperity, Nikola, First Solar
U.S. STOCKS ON THE MOVE-Natgas, Wynn Resorts, Ascendis Pharma
U.S. STOCKS ON THE MOVE-Terran Orbital, SunCoke Energy, Alzamend Neuro
Alzamend Neuro up as FDA allows dementia vaccine trial
Brief: Alzamend Neuro Receives FDA "Study May Proceed" Letter For Phase I/IIA Trial For An Immunotherapy Vaccine (ALZN002) To Treat Mild To Moderate Dementia Of Alzheimer's Type
Brief: Alzamend Neuro Submits Ind Application For Phase I/Iia Trial For An Immunotherapy (Alzn002) To Treat Mild To Moderate Dementia Of The Alzheimer’s Type
Brief: Alzamend Neuro Regains Compliance With Nasdaq's Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP- Fedex, Huntsman, Regeneron Pharmaceuticals
Brief: Alzamend Neuro Says Lien Escalona Resigned As CFO Effective Immediately on Aug 1
U.S. STOCKS ON THE MOVE-Netflix, Kraft Heinz, travel stocks